Challenges of Analyzing Advanced Therapy Medicinal Products (ATMPs)
Source: OmniaBio
Understanding, developing and managing analytical variability is critical to robust and reproducible manufacturing of cell and gene therapy products. Dr Steven Keizer, Director of Quality at CCRM discusses challenges around developing analytics and design-control strategy for QC methods, presented at Bio-Techne’s Cell and Gene Therapy Symposium: Challenges of Analyzing ATMPs.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
OmniaBio
This website uses cookies to ensure you get the best experience on our website. Learn more